Revolution Medicines (RVMD) EBT (2019 - 2026)
Revolution Medicines (RVMD) recorded quarterly EBT of -$453.8 million in Q1 2026, down 159.21% quarter-over-quarter from $766.4 million in Q4 2025, and down 112.64% on a YoY basis from $3.6 billion in Q1 2025.
Revolution Medicines (RVMD) EBT (2019 - 2026) Analysis & Trends
Revolution Medicines' EBT history runs 8 years deep, the most recent figure standing at -$453.8 million for Q1 2026.
- In Q1 2026, EBT fell 112.64% year-over-year to -$453.8 million; the TTM figure through Mar 2026 stood at -$240.4 million (up 65.57% YoY), while the FY2024 annual figure was -$600.8 million, down 36.58% from the prior year.
- EBT was -$453.8 million for Q1 2026 at Revolution Medicines, down from $766.4 million in the prior quarter.
- In the past five years, EBT ranged from a high of $766.4 million in Q4 2025 to a low of -$453.8 million in Q1 2026.
- Historically, EBT has averaged -$102.6 million across 5 years, with a median of -$116.0 million in 2024.
- The sharpest annual moves came in 2023 and 2025: EBT tumbled 184.64% in 2023, then surged 492.48% in 2025.
- A 5-year view of EBT shows it stood at -$56.6 million in 2022, then sank by 184.64% to -$161.2 million in 2023, then dropped by 21.14% to -$195.3 million in 2024, then soared by 492.48% to $766.4 million in 2025, then tumbled by 159.21% to -$453.8 million in 2026.
- The last three EBT figures came in at -$453.8 million (Q1 2026), $766.4 million (Q4 2025), and -$305.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Revolution Medicines | 32.33 Bn | 32.33 Bn | - | -453.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -453.82 Mn |
| Dec 31, 2025 | 766.41 Mn |
| Sep 30, 2025 | -305.21 Mn |
| Jun 30, 2025 | -247.79 Mn |
| Mar 31, 2025 | -213.42 Mn |
| Dec 31, 2024 | -195.27 Mn |
| Sep 30, 2024 | -156.29 Mn |
| Jun 30, 2024 | -133.23 Mn |
| Mar 31, 2024 | -116.00 Mn |
| Dec 31, 2023 | -161.19 Mn |
| Sep 30, 2023 | -112.30 Mn |
| Jun 30, 2023 | -98.30 Mn |
| Mar 31, 2023 | -68.10 Mn |
| Dec 31, 2022 | -56.63 Mn |
| Sep 30, 2022 | -73.63 Mn |
| Jun 30, 2022 | -61.22 Mn |
| Mar 31, 2022 | -57.65 Mn |
| Dec 31, 2021 | -52.68 Mn |
| Sep 30, 2021 | -52.94 Mn |
| Jun 30, 2021 | -44.30 Mn |